On July 16, HCA Healthcare rose 3.06% in regular trading, trading at $390.44/share, with turnover of $170 million. The stock marked its second consecutive session of rebound following a more than 8% plunge triggered by a downward revision to full-year adjusted diluted EPS guidance.

On the news front, the company previously disclosed preliminary Q2 expected revenue of approximately $20.23 billion, significantly exceeding the FactSet consensus estimate of $19.47 billion. Additionally, HCA recognized an extra $400 million in net gains from the Medicaid supplemental payment program during Q2, further bolstering quarterly financials. The market appears to be gradually digesting the earnings guidance cut, shifting focus toward the robust top-line performance that exceeded expectations by nearly $800 million.

The broader Health Care Facilities sector traded higher in sympathy, with Acadia Healthcare up 4.17%, Brookdale Senior Living up 4.15%, Tenet Healthcare up 3.77%, Universal Health up 3.50%, and US Physical Therapy up 5.04%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)